AI-powered prosthetics market seen growing to $3.57 billion by 2030

The Business Research Company says the AI-powered prosthetics market is on track to nearly double from 2025 to 2026 and then more than triple by 2030. The report points to diabetes-driven amputations, faster AI adoption and expanding healthcare infrastructure as major growth drivers.

Why it matters: - AI-powered prosthetics are moving from niche devices to a faster-growing medical technology category. - The market matters because improved control, mobility and adaptability can raise independence for amputees. - Rising diabetes cases are expanding the pool of patients who may need limb replacement devices.

What happened: - The Business Research Company released a 2026 market report on the global AI-powered prosthetics industry. - The market is estimated at $1.71 billion in 2025. - The market is projected to reach $1.98 billion in 2026. - The report forecasts the market will grow to $3.57 billion by 2030. - The report was published July 25, 2026.

The details: - AI-powered prosthetics use artificial intelligence to improve user mobility and control. - The devices learn from muscle signals, neural inputs and environmental factors. - The report says the technology can respond dynamically, unlike conventional prosthetics with preset movements. - Early market growth was held back by limited AI capability in prosthetics, high device costs, low awareness of advanced options, traditional rehabilitation approaches and weak adoption in emerging markets. - The 2026-to-2030 forecast implies a 15.9% CAGR. - The 2025-to-2026 period implies a 15.8% CAGR. - Growth drivers include advances in AI and machine learning, more investment in robotic and myoelectric prosthetics, higher demand from sports and military users, more prosthetic clinics and rehabilitation facilities, and better healthcare infrastructure and insurance coverage. - Emerging trends include more personalized prosthetics, sensor-based feedback systems, rehabilitation and mobility programs, and designs that combine function with cosmetic appeal. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and future trend analysis.

Between the lines: - Diabetes is a central demand driver because the condition can lead to nerve damage, poor circulation and amputations. - The NHS reported pre-diabetes cases in England rose 18% in June 2024, from 3,065,825 in 2022 to 3,615,330 in 2023. - Among people under 40, pre-diabetes cases rose nearly 25%, from 173,166 to 216,440. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period, helped by healthcare investment, rising awareness and manufacturing capacity. - The report signals a market shifting from basic assistive hardware toward more adaptive, data-driven systems.

What's next: - The report expects faster adoption as AI and robotics improve prosthetic performance. - More clinic expansion and stronger insurance support could widen access to advanced prosthetics. - The report points to continued product development around personalization, feedback systems and rehabilitation programs. - Regional competition is likely to intensify as Asia-Pacific scales manufacturing and demand grows.

The bottom line: - AI is turning prosthetics into a faster-growing market with broader clinical and commercial potential, and diabetes-related amputations are likely to keep demand rising.